Overview Financials News + Filings Key Docs Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
Director departure
|
|
Organon & Co.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/03/2021 |
8-K
| Resignation/termination of a director|
Docs:
|
"FORM 8-K",
"Separation and Distribution Agreement, by and between Merck & Co., Inc. and Organon & Co",
"Amended and Restated Certificate of Incorporation of Organon & Co",
"Amended and Restated Bylaws of Organon & Co",
"Tax Matters Agreement, by and between Merck & Co., Inc. and Organon & Co",
"Employee Matters Agreement, by and between Merck & Co., Inc. and Organon & Co",
"Transition Services Agreement, by and between Merck & Co., Inc. and Organon & Co",
"Transition Services Agreement, by and between Merck & Co., Inc. and Organon & Co",
"Indenture, among Organon Finance 1 LLC, Organon Foreign Debt Co-Issuer B.V., U.S. Bank National Association, as trustee and collateral agent, and Elavon Financial Services DAC, UK Branch, as principal paying agent, transfer agent and registrar, with respect to 2.875% Senior Secured Notes due 2028",
"Indenture, among Organon Finance 1 LLC, Organon Foreign Debt Co-Issuer B.V. and U.S. Bank National Association, as trustee and collateral agent, with respect to 4.125% Senior Secured Notes due 2028",
"Indenture, among Organon Finance 1 LLC, Organon Foreign Debt Co-Issuer B.V. and U.S. Bank National Association, as trustee, with respect to 5.125% Senior Notes due 2031" |
|
|
|